Completed OBSERVATIONAL NCT03886350

Implication of UNconventionaL T Lymphocytes in Cystic Fibrosis (UNLOCk) (UNLOCk)

Implication of UNconventionaL T Lymphocytes in Cystic Fibrosis

Sponsor: University Hospital, Tours

Conditions Cystic Fibrosis Inflammatory Response Innate Immunity

Updated 9 times since 2019 Last updated: Jun 22, 2022 Started: Apr 3, 2019 Primary completion: Jul 16, 2020 Completion: Jul 20, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Cystic Fibrosis and Inflammatory Response and is currently completed. University Hospital, Tours leads this study, which shows 9 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jul 2022 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Dec 2021 — Jul 2022 [monthly]

Recruiting
May 2021 — Dec 2021 [monthly]

Recruiting

▶ Show 4 earlier versions

Jan 2021 — May 2021 [monthly]

Recruiting
Nov 2020 — Jan 2021 [monthly]

Recruiting
Jun 2019 — Nov 2020 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Apr 2019 — Jun 2019 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Tours

Data source: University Hospital, Tours

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tours, France